EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal Stem Cell-Based Therapies for Central Nervous System Demyelination: A Review of Nonhuman Models

Li Zhang, Quan Fu Gan, Hoon Koon Teoh, Dongmei Zhao, Guosheng Dong, Xinting Yu, Pooi Pooi Leong

Biomedical Research and Therapy · 31.05.2026 · 13 (05) · 8593-8613

DOI: 10.15419/ag83wq66 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Research and Therapy, online erschienen am 31.05.2026. Verfasst von Li Zhang und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Demyelinating diseases of the central nervous system (CNS), such as multiple sclerosis (MS), are characterized by the progressive loss of myelin, leading to neurological deficits. Current therapies demonstrate limited efficacy in promoting remyelination. This review evaluates the therapeutic potential of mesenchymal stem cells (MSCs) and their derivatives for promoting remyelination in nonhuman models of CNS demyelination.

Methods

A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science for studies published between 2020 and 2024. Inclusion criteria focused on in vivo and in vitro studies utilizing MSCs, MSC-conditioned media (MSC-CM), or extracellular vesicles (EVs) within experimental models of CNS demyelination.

Results

Twenty-four studies met the inclusion criteria. The majority of these investigations demonstrated that MSCs enhance oligodendrocyte progenitor cell (OPC) proliferation and differentiation into mature oligodendrocytes (OLs). Key markers evaluated included NG2, PDGFRα, Olig2, and MBP. Furthermore, MSC-CM and EVs exhibited significant neuroprotective and immunomodulatory effects.

Conclusion

MSC-based therapies exhibit promising regenerative potential within preclinical models of CNS demyelination. These findings support further translational research and the advancement of clinical trials targeting remyelination strategies.

Zitieren

APA

Zhang, L., Gan, Q. F., Teoh, H. K., Zhao, D., Dong, G., Yu, X., & Leong, P. P. (2026). Mesenchymal Stem Cell-Based Therapies for Central Nervous System Demyelination: A Review of Nonhuman Models. Biomedical Research and Therapy, 13(05), 8593-8613. https://doi.org/10.15419/ag83wq66

Vancouver

Zhang L, Gan QF, Teoh HK, Zhao D, Dong G, Yu X, et al. Mesenchymal Stem Cell-Based Therapies for Central Nervous System Demyelination: A Review of Nonhuman Models. Biomedical Research and Therapy. 2026;13(05):8593-8613. doi:10.15419/ag83wq66

BibTeX
@article{Zhang2026,
  author = {Zhang, Li and Gan, Quan Fu and Teoh, Hoon Koon and Zhao, Dongmei and Dong, Guosheng and Yu, Xinting and Leong, Pooi Pooi},
  title = {Mesenchymal Stem Cell-Based Therapies for Central Nervous System Demyelination: A Review of Nonhuman Models},
  journal = {Biomedical Research and Therapy},
  year = {2026},
  volume = {13},
  number = {05},
  pages = {8593--8613},
  doi = {10.15419/ag83wq66}
}
Kostenlos starten →